Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024

BUY
$1.26 - $1.79 $630 - $895
500 New
500 $0
Q2 2022

Jul 07, 2022

SELL
$2.2 - $4.2 $330 - $630
-150 Closed
0 $0
Q4 2021

Jan 19, 2022

SELL
$8.31 - $14.92 $1,246 - $2,238
-150 Reduced 50.0%
150 $1,000
Q3 2021

Oct 15, 2021

BUY
$9.15 - $13.28 $2,745 - $3,984
300 New
300 $3,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.6B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.